• 1
    Murray CJ, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambride (MA): Harvard University Press; 1996.
  • 2
    Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med 2007; 22: 1596602.
  • 3
    Thombs BD, Taillefer SS, Hudson M, Baron M. Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum 2007; 57: 108997.
  • 4
    Margaretten M, Yelin E, Imboden J, Graf J, Barton J, Katz P, et al. Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis. Arthritis Rheum 2009; 61: 158691.
  • 5
    Bansback N, Harrison M, Brazier J, Davies L, Kopec J, Marra C, et al. Health state utility values: a description of their development and application for rheumatic diseases. Arthritis Rheum 2008; 59: 101826.
  • 6
    Kroenke KS, Robert L. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann 2002; 32: 50915.
  • 7
    Wittkampf KA, Naeije L, Schene AH, Huyser J, van Weert HC. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review. Gen Hosp Psychiatry 2007; 29: 38895.
  • 8
    Milette K, Hudson M, Baron M, Thombs BD. Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates. Rheumatology (Oxford) 2010; 49: 78996.
  • 9
    Fries JF, Hochberg MC, Medsger TA Jr, Hunder GG, Bombardier C, and the American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Criteria for rheumatic disease: different types and different functions. Arthritis Rheum 1994; 37: 45462.
  • 10
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994.
  • 11
    Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA 1999; 282: 173744.
  • 12
    Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 60613.
  • 13
    Gilbody S, Richards D, Barkham M. Diagnosing depression in primary care using self-completed instruments: UK validation of PHQ-9 and COREOM. Br J Gen Pract 2007; 57: 6502.
  • 14
    Lowe B, Spitzer RL, Grafe K, Kroenke K, Quenter A, Zipfel S, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord 2004; 78: 13140.
  • 15
    Patient Health Questionnaire (PHQ) screeners. 2011. URL:
  • 16
    Papadimitriou GN, Beratis S, Matsoukas T, Soldatos KR. The Greek translation of the Mini International Neuropsychiatric Interview, MINI 5.0.0. Athens (Greece): Dept. of Psychiatry, University of Athens and Patras, 2004.
  • 17
    Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Amorim P, Janavs J, Weiller E, et al. The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 Suppl 20: 2233.
  • 18
    Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Janavs J, Weiller E, Bonara LI, et al. Reliability and validity of the MINI International Neuropsychiatric Interview (M.I.N.I.): according to the SCID-P. Eur Psychiatry 1997; 12: 23241.
  • 19
    Lecrubier Y, Sheehan D, Weiller E, Amorim P, Bonora I, Sheehan K, et al. The MINI International Neuropsychiatric Interview (M.I.N.I.): a short diagnostic structured interview. Reliability and validity according to the CIDI. Eur Psychiatry 1997; 12: 22431.
  • 20
    Arvaniti A, Livaditis M, Kanioti E, Davis E, Samakouri M, Xenitidis K. Mental health problems in the elderly in residential care in Greece: a pilot study. Aging Ment Health 2005; 9: 1425.
  • 21
    Donias S, Karastergiou A, Manos N. Standardization of the Symptom Checklist-90-R rating scale in a Greek population. Psychiatriki 1991; 2: 428. In Greek.
  • 22
    Derogatis LR. SCL-90-R: administration, scoring, and procedure manual. 3rd ed. Minneapolis: National Computer Systems; 1994.
  • 23
    Ginieri-Coccossis M, Triantafillou E, Tomaras V, Liappas IA, Christodoulou GN, Papadimitriou GN. Quality of life in mentally ill, physically ill and healthy individuals: the validation of the Greek version of the World Health Organization Quality of Life (WHOQOL-100) questionnaire. Ann Gen Psychiatry 2009; 8: 23.
  • 24
    The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998; 28: 5518.
  • 25
    Chatzitheodorou D, Kabitsis C, Papadopoulos NG, Galanopoulou V. Assessing disability in patients with rheumatic diseases: translation, reliability and validity testing of a Greek version of the Stanford Health Assessment Questionnaire (HAQ). Rheumatol Int 2008; 28: 10917.
  • 26
    Little RJ, Rubin DB. Statistical analysis with missing data. New York: Wiley; 1987.
  • 27
    Zuithoff NP, Vergouwe Y, King M, Nazareth I, van Wezep MJ, Moons KG, et al. The Patient Health Questionnaire-9 for detection of major depressive disorder in primary care: consequences of current thresholds in a cross-sectional study. BMC Fam Pract 2010; 11: 98.
  • 28
    Field A. Discovering statistics using SPSS. 2nd ed. London: SAGE Publications; 2005.
  • 29
    Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3: 325.
  • 30
    Pickles A, Dunn G, Vazquez-Barquero JL. Screening for stratification in two-phase (‘two-stage’) epidemiological surveys. Stat Methods Med Res 1995; 4: 7389.
  • 31
    Bruce TO. Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications. Curr Psychiatry Rep 2008; 10: 25864.
  • 32
    Hyphantis TN, Tsifetaki N, Siafaka V, Voulgari PV, Pappa C, Bai M, et al. The impact of psychological functioning upon systemic sclerosis patients' quality of life. Semin Arthritis Rheum 2007; 37: 8192.
  • 33
    Segal B, Bowman SJ, Fox PC, Vivino FB, Murukutla N, Brodscholl J, et al. Primary Sjögren's syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes 2009; 7: 46.
  • 34
    Picardi A, Adler DA, Abeni D, Chang H, Pasquini P, Rogers WH, et al. Screening for depressive disorders in patients with skin diseases: a comparison of three screeners. Acta Derm Venereol 2005; 85: 4149.
  • 35
    McManus D, Pipkin SS, Whooley MA. Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). Am J Cardiol 2005; 96: 107681.
  • 36
    Julian LJ, Gregorich SE, Tonner C, Yazdany J, Trupin L, Criswell LA, et al. Using the CES-D to screen for depression in SLE. Arthritis Care Res (Hoboken) 2011; 63: 88490.
  • 37
    Lok EY, Mok CC, Cheng CW, Cheung EF. Prevalence and determinants of psychiatric disorders in patients with rheumatoid arthritis. Psychosomatics 2010; 51: 338.
  • 38
    Dickens C, Jackson J, Tomenson B, Hay E, Creed F. Association of depression and rheumatoid arthritis. Psychosomatics 2003; 44: 20915.
  • 39
    Baubet T, Ranque B, Taieb O, Berezne A, Bricou O, Mehallel S, et al. Mood and anxiety disorders in systemic sclerosis patients. Presse Med 2011; 40: e1119.
  • 40
    Nery FG, Borba EF, Hatch JP, Soares JC, Bonfa E, Neto FL. Major depressive disorder and disease activity in systemic lupus erythematosus. Compr Psychiatry 2007; 48: 149.
  • 41
    Jarpa E, Babul M, Calderon J, Gonzalez M, Martinez ME, Bravo-Zehnder M, et al. Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity. Lupus 2011; 20: 5866.
  • 42
    Bachen EA, Chesney MA, Criswell LA. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum 2009; 61: 8229.
  • 43
    Diez-Quevedo C, Rangil T, Sanchez-Planell L, Kroenke K, Spitzer RL. Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients. Psychosom Med 2001; 63: 67986.
  • 44
    Fann JR, Bombardier CH, Dikmen S, Esselman P, Warms CA, Pelzer E, et al. Validity of the Patient Health Questionnaire-9 in assessing depression following traumatic brain injury. J Head Trauma Rehabil 2005; 20: 50111.
  • 45
    Huang FY, Chung H, Kroenke K, Delucchi KL, Spitzer RL. Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients. J Gen Intern Med 2006; 21: 54752.
  • 46
    Gilbody S, Sheldon T, House A. Screening and case-finding instruments for depression: a meta-analysis. CMAJ 2008; 178: 9971003.
  • 47
    Callahan EJ, Bertakis KD, Azari R, Robbins J, Helms LJ, Miller J. The influence of depression on physician-patient interaction in primary care. Fam Med 1996; 28: 34651.
  • 48
    Sleath B, Chewning B, de Vellis BM, Weinberger M, de Vellis RF, Tudor G, et al. Communication about depression during rheumatoid arthritis patient visits. Arthritis Rheum 2008; 59: 18691.
  • 49
    Nicassio PM. The problem of detecting and managing depression in the rheumatology clinic. Arthritis Rheum 2008; 59: 1558.
  • 50
    Leentjens AF. Recognizing depression in physical illness: clinical alertness, case finding, or screening? J Psychosom Res 2010; 68: 5079.
  • 51
    Pignone MP, Gaynes BN, Rushton JL, Burchell CM, Orleans CT, Mulrow CD, et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 136: 76576.